Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 4/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.49 |
| ▸ | POLA1 | P09884 | 1/20 | 0.46 |
| ▸ | SRD5A1 | P18405 | 4/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.43 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | OSBP | P22059 | 2/20 | 0.41 |
| ▸ | OSBP2 | Q969R2 | 2/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 2/20 | 0.40 |
| ▸ | FNTB | P49356 | 2/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11994854 | 0.93 | CDC25A (0.48) | CDC25ACYP2D6CYP2C19INPP5DPOLA1 | |
| SCHEMBL10018004 | 0.89 | CYP2D6 (0.49) | CDC25ACYP2D6CYP2C19INPP5DPOLA1 | |
| SCHEMBL105651 | 0.88 | CDC25A (0.57) | CDC25ACYP2D6CYP2C19INPP5DPOLA1 | |
| SCHEMBL12172545 | 0.86 | CYP2D6 (0.51) | CDC25ACYP2D6CYP2C19INPP5DPOLA1 | |
| SCHEMBL10017576 | 0.85 | CDC25A (0.45) | CDC25ACYP2D6CYP2C19INPP5DPOLA1 | |
| SCHEMBL1688873 | 0.85 | CYP2D6 (0.53) | CDC25ACYP2D6CYP2C19INPP5DPOLA1 | |
| SCHEMBL14780854 | 0.85 | CDC25A (0.53) | CDC25ACYP2D6CYP2C19INPP5DPOLA1 | |
| SCHEMBL14444885 | 0.85 | CDC25A (0.53) | CDC25ACYP2D6CYP2C19INPP5DPOLA1 | |
| SCHEMBL10054763 | 0.84 | CYP2D6 (0.55) | CDC25ACYP2D6CYP2C19INPP5DPOLA1 | |
| SCHEMBL11994853 | 0.84 | CDC25A (0.47) | CDC25ACYP2D6CYP2C19INPP5DPOLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9541795-B2 | Liquid crystal display device and method for manufacturing the same | SONY CORPORATION (JP) | 2017-01-10 | — | — | US | disclosed |
| US-9523889-B2 | Liquid crystal display unit and method of manufacturing the same | SONY CORPORATION (JP) | 2016-12-20 | — | — | US | disclosed |
| US-9507210-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2016-11-29 | — | — | US | disclosed |
| US-9470929-B2 | Liquid crystal display unit and method of manufacturing the same | SONY CORPORATION (JP) | 2016-10-18 | — | — | US | disclosed |
| US-9465244-B2 | Liquid crystal display | SONY CORPORATION (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9366910-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2016-06-14 | — | — | US | disclosed |
| US-20160011463-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-9235084-B2 | Liquid crystal display device and manufacturing method thereof | SONY CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9146425-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| US-20150146148-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2015-05-28 | — | — | US | disclosed |
| US-20140111752-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2014-04-24 | — | — | US | disclosed |
| US-20140071390-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2014-03-13 | — | — | US | disclosed |
| US-20130155360-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2013-06-20 | — | — | US | disclosed |
| US-20130010244-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION | 2013-01-10 | — | — | US | disclosed |
| US-20120218500-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2012-08-30 | — | — | US | disclosed |
| US-20120212691-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120026440-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20110273652-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110157531-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
| US-20110134382-A1 | LIQUID CRYSTAL DISPLAY ELEMENT AND LIQUID CRYSTAL DISPLAY DEVICE | SONY CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160011463-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | PYM1, PDCD2L, SDAD1 | CDC25A 73/4885CYP2D6 4037/4885CYP2C19 3841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.